SIGMA 270997-100ML DCM 75-09-2
文献支持

SIGMA 270997-100ML DCM 75-09-2

收藏
  • ¥570
  • Sigma-Aldrich
  • 进口
  • 270997-100ML
  • 2025年07月14日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      常温

    • 保质期

      根据瓶身LOT号查询

    • 英文名

      Dichloromethane

    • 库存

      有现货

    • 供应商

      浙江羽翔生物科技有限公司

    • CAS号

      75-09-2

    • 规格

      100ML

    属性

    等级

    anhydrous

    质量水平

    200

    Agency

    suitable for EPA 1613

    蒸汽密度

    2.9 (vs air)

    蒸汽压

    24.45 psi ( 55 °C)
    6.83 psi ( 20 °C)
    6.86 psi ( 20 °C)

    方案

    ≥99.8%

    表单

    liquid

    自燃温度

    1223 °F

    包含

    40-150 ppm amylene as stabilizer

    expl. lim.

    22 %

    技术

    gas chromatography (GC): suitable

    杂质

    ≤0.001% water
    ≤0.005% water (100 mL pkg)

    蒸发残留物

    <0.0005%

    折射率

    n20/D 1.424 (lit.)

    沸点

    39.8-40 °C (lit.)

    mp

    −95 °C (lit.)

    密度

    1.325 g/mL at 25 °C (lit.)

    SMILES字符串

    ClCCl

    InChI

    1S/CH2Cl2/c2-1-3/h1H2

    InChI key

    YMWUJEATGCHHMB-UHFFFAOYSA-N

    一般描述

    DCM是一种氯化有机溶剂,易随时间降解。添加戊烯作为稳定剂可抑制其降解。
    对DCM作为二吡啶-氧化铬(VI)的溶剂介质进行了测试。据报道,溶解度为12.5 g/100 ml。研究了活性炭载体上TiO2负载量对DCM光分解的作用。

    应用

    DCM可用于气相色谱法(GC)定量检测草食性动物(舞毒蛾)诱导的蓝莓挥发物。
    DCM可用作使用二吡啶-氧化铬(VI)氧化伯醇和仲醇的溶剂。悬浮于DCM中的高氯酸li是醛与甲硅wan基乙烯酮缩醛进行Mukaiyama醇醛缩合反应的有效介质。DCM也可用作通过锂-溴交换反应由2,6-二溴吡啶合成2-溴-6-硫代吡啶的溶剂。

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    Optimum 3D Matrix Stiffness for Maintenance of Cancer Stem Cells Is Dependent on Tissue Origin of Cancer Cells.

    PloS one (2015-07-15)
    Esmaiel Jabbari, Samaneh K Sarvestani, Leily Daneshian, Seyedsina Moeinzadeh
    PMID26168187
    摘要

    The growth and expression of cancer stem cells (CSCs) depend on many factors in the tumor microenvironment. The objective of this work was to investigate the effect of cancer cells' tissue origin on the optimum matrix stiffness for CSC growth and marker expression in a model polyethylene glycol diacrylate (PEGDA) hydrogel without the interference of other factors in the microenvironment. Human MCF7 and MDA-MB-231 breast carcinoma, HCT116 colorectal and AGS gastric carcinoma, and U2OS osteosarcoma cells were used. The cells were encapsulated in PEGDA gels with compressive moduli in the 2-70 kPa range and optimized cell seeding density of 0.6x106 cells/mL. Micropatterning was used to optimize the growth of encapsulated cells with respect to average tumorsphere size. The CSC sub-population of the encapsulated cells was characterized by cell number, tumorsphere size and number density, and mRNA expression of CSC markers. The optimum matrix stiffness for growth and marker expression of CSC sub-population of cancer cells was 5 kPa for breast MCF7 and MDA231, 25 kPa for colorectal HCT116 and gastric AGS, and 50 kPa for bone U2OS cells. Conjugation of a CD44 binding peptide to the gel stopped tumorsphere formation by cancer cells from different tissue origin. The expression of YAP/TAZ transcription factors by the encapsulated cancer cells was highest at the optimum stiffness indicating a link between the Hippo transducers and CSC growth. The optimum average tumorsphere size for CSC growth and marker expression was 50 μm. The marker expression results suggest that the CSC sub-population of cancer cells resides within a niche with optimum stiffness which depends on the cancer cells' tissue origin.

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥634
    嘉兴亦高医疗器械有限公司
    2025年12月18日询价
    ¥326
    北京德航五洲科技有限公司
    2025年12月02日询价
    询价
    谱析(上海)生物科技有限公司
    2024年01月25日询价
    ¥99
    上海鹿森生物工程有限公司
    2025年07月12日询价
    ¥704
    浙江羽翔生物科技有限公司
    2025年11月02日询价
    文献支持
    SIGMA 270997-100ML DCM 75-09-2
    ¥570